TR200904341A2 - Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler. - Google Patents

Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.

Info

Publication number
TR200904341A2
TR200904341A2 TR2009/04341A TR200904341A TR200904341A2 TR 200904341 A2 TR200904341 A2 TR 200904341A2 TR 2009/04341 A TR2009/04341 A TR 2009/04341A TR 200904341 A TR200904341 A TR 200904341A TR 200904341 A2 TR200904341 A2 TR 200904341A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
rosuvastatin calcium
compositions containing
stable pharmaceutical
containing rosuvastatin
Prior art date
Application number
TR2009/04341A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/04341A priority Critical patent/TR200904341A2/tr
Priority to PCT/TR2010/000103 priority patent/WO2010140992A1/en
Publication of TR200904341A2 publication Critical patent/TR200904341A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, en az % 60 oranında laktoz içermek suretiyle kararlı hale gelen, oral rosuvastatin kalsiyum fannasötik bileşimine, bu bileşimin hazırlanması için yöntemlere ve hazırlanan bileşimin tedavi amaçlı kullanımına dairdir.
TR2009/04341A 2009-06-03 2009-06-03 Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler. TR200904341A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/04341A TR200904341A2 (tr) 2009-06-03 2009-06-03 Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.
PCT/TR2010/000103 WO2010140992A1 (en) 2009-06-03 2010-05-27 Stable pharmaceutical compositions containing rosuvastatin calcium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/04341A TR200904341A2 (tr) 2009-06-03 2009-06-03 Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.

Publications (1)

Publication Number Publication Date
TR200904341A2 true TR200904341A2 (tr) 2010-12-21

Family

ID=43020424

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/04341A TR200904341A2 (tr) 2009-06-03 2009-06-03 Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.

Country Status (2)

Country Link
TR (1) TR200904341A2 (tr)
WO (1) WO2010140992A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101302306B1 (ko) 2011-01-26 2013-09-03 씨제이제일제당 (주) 고지혈증 복합제
CN104434826B (zh) * 2014-11-08 2018-03-20 鲁南贝特制药有限公司 一种瑞舒伐他汀钙分散片
KR20220026641A (ko) * 2020-08-25 2022-03-07 주식회사 대웅제약 고혈압 및 고지혈증을 치료 또는 예방하기 위한 단일 제형의 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
HU217629B (hu) 1991-12-12 2000-03-28 Novartis Ag. Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
HU227610B1 (en) 2006-09-18 2011-09-28 Richter Gedeon Nyrt Pharmaceutical compositions containing rosuvastatin potassium
WO2008062476A2 (en) * 2006-10-31 2008-05-29 Glenmark Pharmaceutical Limited Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
GB0713707D0 (en) * 2007-07-13 2007-08-22 Generics Uk Ltd Stable compositions
CA2637977A1 (en) * 2008-07-15 2010-01-15 Pharmascience Inc. Dosage form containing a statin
PL386051A1 (pl) * 2008-09-09 2010-03-15 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Stabilna doustna kompozycja farmaceutyczna zawierająca farmaceutycznie dopuszczalną sól kwsu [(E)-7-[4-(4-fluorofenylo)-6-izopropylo-2-[metylo(metylosulfonylo)amino]pirymidyn-5-ylo] (3R,5S)-3,5-dihydroksyhept-6-enowego
TR200902077A2 (tr) * 2009-03-17 2010-01-21 Sanovel İlaç San.Veti̇c.A.Ş. Stabil rosuvastatin kompozisyonları

Also Published As

Publication number Publication date
WO2010140992A1 (en) 2010-12-09

Similar Documents

Publication Publication Date Title
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
MX348823B (es) Formulaciones estables de linaclotida.
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
EA200971115A1 (ru) Новые ингибиторы обратной транскриптазы вич
MX2009010977A (es) Metodos de administracion de tetrahidrobiopterina, composiciones asociadas y metodos de medicion.
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
EA201200794A1 (ru) Триазолопиридины
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
EA201001639A1 (ru) Композиции и способы их получения и применения
MX2011011486A (es) Composiciones orales que contienen compuestos de poliguandino y metodos de preparacion y uso de las mismas.
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
EA201190017A1 (ru) Аминоэфирные производные алкалоидов и их медицинские композиции
GB2511685A (en) Muscarinic m1 receptor agonists
EP2528578A4 (en) DENTAL COMPOSITION USING A CALCIUM SOURCE
UA112055C2 (uk) Солі 4-[2-[[5-метил-1-(2-нафталініл)-1h-піразол-3-іл]оксі]етил]морфоліну
EA200970065A1 (ru) Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
EA201590364A1 (ru) Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда
EA201000434A1 (ru) Сокристаллы пириметанила и дитианона